Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Inventory Average (2016 - 2025)

Vanda Pharmaceuticals (VNDA) has disclosed Inventory Average for 14 consecutive years, with $6.5 million as the latest value for Q4 2025.

  • Quarterly Inventory Average fell 31.44% to $6.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Dec 2025, down 31.44% year-over-year, with the annual reading at $10.3 million for FY2025, 88.9% up from the prior year.
  • Inventory Average hit $6.5 million in Q4 2025 for Vanda Pharmaceuticals, up from $6.2 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $10.3 million in Q3 2022 to a low of $963500.0 in Q4 2021.
  • Historically, Inventory Average has averaged $5.0 million across 5 years, with a median of $5.5 million in 2023.
  • Biggest five-year swings in Inventory Average: surged 955.44% in 2022 and later plummeted 80.71% in 2023.
  • Year by year, Inventory Average stood at $963500.0 in 2021, then skyrocketed by 535.76% to $6.1 million in 2022, then tumbled by 80.71% to $1.2 million in 2023, then surged by 706.22% to $9.5 million in 2024, then crashed by 31.44% to $6.5 million in 2025.
  • Business Quant data shows Inventory Average for VNDA at $6.5 million in Q4 2025, $6.2 million in Q3 2025, and $10.3 million in Q2 2025.